Objective: To evaluate how distinct presentations of anxiety symptoms and intellectual impairment influence the measurement and estimated rate of clinically significant anxiety in autism spectrum disorder (ASD).Method: The sample included 75 children (ages 9-13 years) with ASD and varied IQ and 52 typically developing (TD) controls and parents. Parents completed anxiety symptom scales and a diagnostic interview, designed to (1) differentiate anxiety and ASD and (2) examine DSM-specified and unspecified ("distinct") anxiety presentations in each child, including fears of change, special interests, idiosyncratic stimuli and social confusion rather than evaluation. Children completed standard intellectual and ASD diagnostic assessments. Results: 69% of those with ASD had clinically-significant anxiety, including 21% DSM-specified anxiety disorders, 17% distinct anxiety, and 31% both. Only 8% of TD children had clinically-significant anxiety, all DSM-specified. DSM-specified anxiety disorders in children with ASD and intellectual impairment (IQ<70) were predominantly specific phobias. DSM-specified anxiety other than specific phobia was significantly less common in children with, versus without, intellectual impairment; this was not the case for distinct anxiety. The sensitivities of anxiety scales were moderate to poor, particularly in cases with intellectual impairment.Conclusions: ASD is associated with more frequent and varied presentations of clinical anxiety, which may align with and differ from the specified anxiety disorders of the DSM. Standard parent report anxiety scales have reduced sensitivity to detect clinical anxiety in ASD, particularly in children with intellectual impairment.
Objective: To evaluate how distinct presentations of anxiety symptoms and intellectual impairment influence the measurement and estimated rate of clinically significant anxiety in autism spectrum disorder (ASD).Method: The sample included 75 children (ages 9-13 years) with ASD and varied IQ and 52 typically developing (TD) controls and parents. Parents completed anxiety symptom scales and a diagnostic interview, designed to (1) differentiate anxiety and ASD and (2) examine DSM-specified and unspecified ("distinct") anxiety presentations in each child, including fears of change, special interests, idiosyncratic stimuli and social confusion rather than evaluation. Children completed standard intellectual and ASD diagnostic assessments. Results: 69% of those with ASD had clinically-significant anxiety, including 21% DSM-specified anxiety disorders, 17% distinct anxiety, and 31% both. Only 8% of TD children had clinically-significant anxiety, all DSM-specified. DSM-specified anxiety disorders in children with ASD and intellectual impairment (IQ<70) were predominantly specific phobias. DSM-specified anxiety other than specific phobia was significantly less common in children with, versus without, intellectual impairment; this was not the case for distinct anxiety. The sensitivities of anxiety scales were moderate to poor, particularly in cases with intellectual impairment.Conclusions: ASD is associated with more frequent and varied presentations of clinical anxiety, which may align with and differ from the specified anxiety disorders of the DSM. Standard parent report anxiety scales have reduced sensitivity to detect clinical anxiety in ASD, particularly in children with intellectual impairment.
Authors: B Birmaher; D A Brent; L Chiappetta; J Bridge; S Monga; M Baugher Journal: J Am Acad Child Adolesc Psychiatry Date: 1999-10 Impact factor: 8.829
Authors: Eric A Storch; Jill Ehrenreich May; Jeffrey J Wood; Anna M Jones; Alessandro S De Nadai; Adam B Lewin; Elysse B Arnold; Tanya K Murphy Journal: J Child Adolesc Psychopharmacol Date: 2012-08-02 Impact factor: 2.576
Authors: Breanna Winder-Patel; Megan E Tudor; Connor M Kerns; Konnor Davis; Christine Wu Nordahl; David G Amaral; Marjorie Solomon Journal: Evid Based Pract Child Adolesc Ment Health Date: 2021-10-12
Authors: Michelle C Hunsche; Matti Cervin; Eric A Storch; Philip C Kendall; Jeffrey J Wood; Connor M Kerns Journal: J Psychopathol Clin Sci Date: 2022-02
Authors: Christopher J McDougle; Robyn P Thom; Caitlin T Ravichandran; Michelle L Palumbo; Laura C Politte; Jennifer E Mullett; Christopher J Keary; Craig A Erickson; Kimberly A Stigler; Lauren Mathieu-Frasier; David J Posey Journal: Neuropsychopharmacology Date: 2022-03-03 Impact factor: 8.294
Authors: Hannah E Frank; Elana R Kagan; Eric A Storch; Jeffrey J Wood; Connor M Kerns; Adam B Lewin; Brent J Small; Philip C Kendall Journal: J Clin Child Adolesc Psychol Date: 2020-06-08
Authors: Christine Wu Nordahl; Derek Sayre Andrews; Patrick Dwyer; Einat Waizbard-Bartov; Bibiana Restrepo; Joshua K Lee; Brianna Heath; Clifford Saron; Susan M Rivera; Marjorie Solomon; Paul Ashwood; David G Amaral Journal: Front Neurosci Date: 2022-01-17 Impact factor: 4.677